O transplante de ilhotas pancreáticas humanas é considerado uma estratégia promissora para curar pacientes portadores de Diabetes Mellitus tipo 1. Entretanto, sua eficiência é dramaticamente afetada pelo rendimento das ilhotas no processo de isolamento/purificação e pela viabilidade das células após o transplante. As ilhotas pancreáticas isoladas são obtidas através da perfusão do pâncreas com colagenase e purificação em gradiente de densidade. As espécies reativas de oxigênio (ERO) exercem um papel importante durante a obtenção e o transplante de ilhotas pancreáticas humanas, contribuindo significativamente para diminuir a viabilidade dessas células. Nesse trabalho foram avaliadas as respostas oxidativas de ilhotas pancreáticas humanas durante os processos de isolamento/purificação e cultivo. As atividades da superóxido dismutase (SOD), da catalase, bem como os níveis de oxidação em proteínas mostraram-se, na maioria dos casos, aumentados, principalmente durante a etapa de purificação das ilhotas em gradiente de Ficoll e no período de cultura das ilhotas. Esses resultados indicam que a purificação em gradiente de Ficoll parece ser uma etapa crítica de geração das ERO, assim como longos períodos de cultivo. Porém, verificou-se que influências advindas dos diferentes doadores (idade, causa- mortis, estilo de vida, etc.) e condições de preservação do órgão (tempo de isquemia, solução de conservação, etc.) poderiam estar relacionadas à discrepância de alguns resultados encontrados. Com o intuito de minimizar tais variáveis, optou-se por estudar os efeitos relacionados ao Ficoll em células de insulinoma INS-1E, um modelo celular fisiologicamente semelhante. Para tanto, as atividades das enzimas antioxidantes SOD, catalase, glutationa peroxidase (GPx) e glutationa redutase (GR), assim como os danos oxidativos em proteínas e lipídeos, os níveis de glutationa reduzida (GSH) e de glutationa oxidada (GSSG), a viabilidade celular e os níveis de algumas enzimas envolvidas no processo apoptótico como p38, JNK-1, ERK 1-2 e PI3-K expostas a polissacarose (1100 mg/mL), um genérico do Ficoll, foram determinadas. De acordo com os resultados, as atividades da SOD, catalase e GPx presentes em amostras expostas a polissacarose mostraram-se aumentadas. Em cultura, a atividade de isoforma mitocondrial da SOD (Mn-SOD) de células INS-1E correspondeu a 50% da atividade total da SOD. Na presença da polissacarose, a atividade da Mn-SOD aumentou para 80% do total. Além disso, a oxidação de lipídios e de proteínas aumentou e os níveis de GSH e GR diminuíram discretamente. Estes resultados mostraram que a exposição dessas células a polissacarose está associada com o estresse oxidativo. Entretanto, tal exposição não foi responsável pela diminuição da viabilidade celular embora os níveis protéicos de JNK-1, ERK1-2 e PI3-K tenham se mostrado consideravelmente aumentados e os níveis de p38, diminuídos. Os níveis de expressão e a atividade de enzimas antioxidantes são conhecidamente baixos em ilhotas pancreáticas. A N-acetilcisteína (NAC) foi adicionada em cultura de células para prevenir o estresse oxidativo. Nessas condições, a NAC foi capaz de proteger as células INS-1E do estresse oxidativo induzido. Esses resultados sugerem que a exposição à polissacarose está associdada ao estresse oxidativo em células INS-1E e que a NAC foi capaz de prevenir a morte celular de células INS-1E expostas a ERO através do aumento intracelular de GSH. / Human pancreatic islet transplantation is considered a promising strategy to cure the cure Diabetes Mellitus type I. However, transplantation efficiency is dramatically affected by sub-optimum islet recovery in the isolation/purification procedure and islet viability after transplantation. Isolated pancreatic islets are obtained through collagenase perfusion and cell purification in a Ficoll gradient. Reactive oxygen species (ROS) play an important role during human pancreatic islet isolation and may contribute to the decrease in cell viability. The aim of this study was evaluated the response of human pancreatic islets during its isolation/purification and culture time. Activities of superoxide dismutase (SOD) and catalase as well as protein oxidation levels increased in most of analyzed samples, mainly during the Ficoll gradient islet purification step and further culture. Ficoll seems to be the critical step for ROS generation. Nevertheless, it was observed that donors characteristics (aging, cause of death, habits, etc.) and organ preservation conditions (ischemic time, preservation solution, etc.) may be related to our results. To minimize these variations, a physiological cellular model based on INS-1E cells was chosen. The antioxidant enzymes SOD, catalase, glutathione peroxidase (GPx) and glutathione reductase (GR) activities as well the oxidative damage to proteins and lipids, reduced glutathione (GSH) and oxidized glutathione (GSSG) levels, cellular viability and the protein levels of some enzymes responsible for apoptotic signaling like p38, JNK-1, ERK 1-2 and PI3-K upon exposure to polysucrose (1100 mg/mL), a similar of Ficoll, were determined. The SOD, catalase and GPx in samples exposed to polysucrose displayed hight activities. In all cultures, the activity of mitochondrial isoform of SOD (Mn-SOD) corresponds to 50% of total SOD activity. In the presence of polysucrose, the activity of Mn-SOD increased up to 80%. Lipids and protein oxidation levels were also increased and the GSH levels with the GR activity decreased. These results indicated that the exposure of INS-1E cells to polysucrose is associated with oxidative stress. However, the polysucrose exposure was not responsible for cell death although JNK-1, ERK1-2 and PI3-K levels showed hight levels but not p38, upon polysucrose exposure. The expression and activities of antioxidants enzymes are known to be very low in pancreatic islets. N-acetylcysteine (NAC) was added to the INS-1E cultures to prevent oxidative stress. Under these conditions, NAC was able to protect INS- 1E cells from induced oxidative damage by increasing intracellular GSH levels. Taken together, these results suggest that the exposure to polysucrose is related to the oxidative stress in INS-1E cells and NAC seems to be able to maintain cell viability.

<p><strong>Aim: </strong>To investigate the quality of life and the social life situation, with special focus on the consequenses of fear of hypoglycemia (FoH), in Islet transplanted patients.</p><p><strong>Method: </strong>11 patients were included, four women and seven men, who have been Islet tranplanted at Uppsala University Hospital during the years 2001-2009. Two questionaires, Short Form 36 (SF-36) and the Swedish version Hypoglycemia Fear Survey (Swe-HFS) were used to investigate the quality of life, in relation to fear of hypoglycemia. Also, telephone interviews were conducted to investigate the patients social life situation in relation to FoH, after Islet transplantation and were analysed using content analysis method.</p><p><strong>Results:</strong> The mean value for quality of life was lower than that in the normal population. Three out of ten patients experienced FoH. Three predominant themes were revealed, one theme associated with pre- transplant, was “Struggle for control of Social Life Situation” and two themes associated with post-transplant, were “Regain power and controll of  Social Life Situation” and “At Peace with the balance between the Present and the Future”.</p><p><strong>Conclusion:</strong> The patients experienced improved control over social life situation and quality of life in relation to FoH may been improved following islet tranplantation.</p> / <p><strong>Syfte: </strong>Att undersöka ö-cellstransplanterade patienters livskvalitet och sociala livssituation med speciellt fokus på oro/rädsla för hypoglykemi.</p><p><strong>Metod</strong>: I studien inkluderades 11 patienter, fyra kvinnor och sju män, vilka genomgått ö-cellstransplantation vid Akademiska Sjukhuset i Uppsala under perioden 2001-2009. Två frågeformulär, Short Form 36 (SF-36) och den svenska versionen av Hypoglycemia Fear Survey (Swe-HFS) användes för att undersöka patienternas livskvalitet relaterat till oro/rädsla för hypoglykemi. Telefonintervjuer genomfördes för att undersöka patienternas sociala livssituation efter genomgången ö-cellstransplantation relaterat till oro/rädsla för hypoglykemi och analyserats med innehållsanalys.</p><p><strong>Resultat: </strong>Medelvärdet för hälsorelaterad livskvalitet var lägre jämfört med normalbefolkningen och tre av tio deltagare upplevde oro/rädsla för hypoglykemi. Tre övergripande teman med koppling till social livssituation identifierades, ett tema före genomgången ö-cellstransplantation, var ”Kampen om kontroll över social livssituation”, och två teman efter genomförd transplantation, var ”Återtagande av makt och kontroll över social livssituation” samt ”Tillfreds med balans mellan nuet och framtiden”.<strong></strong></p><p><strong>Konklusion: </strong>Patienterna upplevde att kontrollen över den sociala livssituationen och livskvalitet i relation till oro/rädsla för hypoglykemi förbättrades efter genomgången ö-cellstransplantation.</p>

<p>The blood vessels of the pancreatic islets are of crucial importance for oxygen and metabolite supply as well as dispersal of secreted hormones. In addition to this, endothelial cells have an important role in the revascularization process after islet transplantation. Previous studies have reported signs of poor engraftment of transplanted islets, presumably due to impaired revascularization. The aims of this thesis were to investigate the revascularization process of transplanted islets and to examine the role of islet endothelial cells. In this context, the lectin Bandeiraea simplicifolia was found to stain endothelium of both endogenous and transplanted pancreatic islets. By using this lectin we investigated the vascular density of both endogenous and islets transplanted syngeneically beneath the renal capsule, into the spleen or intraportally into the liver of normoglycemic C57BL/6 mice. One month post-transplantation, a time point when the grafts are assumed to be completely revascularized, the vascular density was decreased at all three implantation sites when compared to endogenous islets. Furthermore, most of the blood vessels were located in the graft connective tissue stroma. Similar results were obtained when islet transplant vascular density was determined six months post-transplantation and in cured diabetic animals after one month. In order to evaluate the function of intraportally transplanted islets, we developed a method to retrieve such islets. We treated the implantation organ (liver) first enzymatically (collagenase) and then mechanically, thereafter we could re-isolate the transplanted islets for further in vitro studies. The retrieved islets had a decreased insulin relase, insulin content and glucose oxidation rate when compared to non-transplanted control islets. To understand the role of islet endothelium in the revascularization of transplanted islets we performed angiogenesis GEArray studies on islet endothelial cells, from non-cultured, cultured and transplanted islets. We found that the islet endothelium expressed mRNA for both inhibitors and inducers of angiogenesis, and that this expression differed with time. The functional consequences of this remain to be determined. In summary, the results presented above provide a useful platform for future studies of the morphology and function of islet endothelial cells, especially with a view for elucidating changes induced by islet transplantation.</p>

<p>Transplanting pancreatic islets into the liver through the portal vein is currently the most common procedure in clinical islet transplantations for treating patients with brittle type 1 diabetes. However, most islet grafts fail within a 5-year period necessitating retransplantation. The vascular connections are disrupted at islet isolation and implanted islets depend on diffusion of oxygen and nutrients in the immediate posttransplantation period. Rapid and efficient revascularization is of utmost importance for the survival and long-term function of transplanted islets. </p><p>In this thesis, the influence of the implantation microenvironment for islet engraftment and function was studied. Islets were transplanted into the liver, the renal subcapsular site or the pancreas. Islets implanted into the liver contained fewer glucagon-positive cells than islets implanted to the kidney and endogenous islets. Intraportally transplanted islets responded with insulin and glucagon release to secretagogues, but only when stimulated through the hepatic artery. Thus, the intrahepatic grafts were selectively revascularized from the hepatic artery. The vascular density in human islets transplanted into the liver of athymic mice was markedly lower when compared to human islets grafted to the kidney. Islets implanted into their physiological environment, the pancreas, were markedly better revascularized. Insulin content, glucose-stimulated insulin release, (pro)insulin biosynthesis and glucose oxidation rate were markedly decreased in transplanted islets retrieved from the liver, both when compared to endogenous and transplanted islets retrieved from the pancreas. Only minor changes in metabolic functions were observed in islets implanted into the pancreas when compared to endogenous islets. </p><p>The present findings demonstrate that the microenvironment has a major impact on the engraftment of transplanted islets. Elucidating the beneficial factors that promote engraftment would improve the survival and long-term function of transplanted islets. Ultimately, islet transplantation may be provided to an increased number of patients with type 1 diabetes.</p>

The blood vessels of the pancreatic islets are of crucial importance for oxygen and metabolite supply as well as dispersal of secreted hormones. In addition to this, endothelial cells have an important role in the revascularization process after islet transplantation. Previous studies have reported signs of poor engraftment of transplanted islets, presumably due to impaired revascularization. The aims of this thesis were to investigate the revascularization process of transplanted islets and to examine the role of islet endothelial cells. In this context, the lectin Bandeiraea simplicifolia was found to stain endothelium of both endogenous and transplanted pancreatic islets. By using this lectin we investigated the vascular density of both endogenous and islets transplanted syngeneically beneath the renal capsule, into the spleen or intraportally into the liver of normoglycemic C57BL/6 mice. One month post-transplantation, a time point when the grafts are assumed to be completely revascularized, the vascular density was decreased at all three implantation sites when compared to endogenous islets. Furthermore, most of the blood vessels were located in the graft connective tissue stroma. Similar results were obtained when islet transplant vascular density was determined six months post-transplantation and in cured diabetic animals after one month. In order to evaluate the function of intraportally transplanted islets, we developed a method to retrieve such islets. We treated the implantation organ (liver) first enzymatically (collagenase) and then mechanically, thereafter we could re-isolate the transplanted islets for further in vitro studies. The retrieved islets had a decreased insulin relase, insulin content and glucose oxidation rate when compared to non-transplanted control islets. To understand the role of islet endothelium in the revascularization of transplanted islets we performed angiogenesis GEArray studies on islet endothelial cells, from non-cultured, cultured and transplanted islets. We found that the islet endothelium expressed mRNA for both inhibitors and inducers of angiogenesis, and that this expression differed with time. The functional consequences of this remain to be determined. In summary, the results presented above provide a useful platform for future studies of the morphology and function of islet endothelial cells, especially with a view for elucidating changes induced by islet transplantation.

Transplanting pancreatic islets into the liver through the portal vein is currently the most common procedure in clinical islet transplantations for treating patients with brittle type 1 diabetes. However, most islet grafts fail within a 5-year period necessitating retransplantation. The vascular connections are disrupted at islet isolation and implanted islets depend on diffusion of oxygen and nutrients in the immediate posttransplantation period. Rapid and efficient revascularization is of utmost importance for the survival and long-term function of transplanted islets. In this thesis, the influence of the implantation microenvironment for islet engraftment and function was studied. Islets were transplanted into the liver, the renal subcapsular site or the pancreas. Islets implanted into the liver contained fewer glucagon-positive cells than islets implanted to the kidney and endogenous islets. Intraportally transplanted islets responded with insulin and glucagon release to secretagogues, but only when stimulated through the hepatic artery. Thus, the intrahepatic grafts were selectively revascularized from the hepatic artery. The vascular density in human islets transplanted into the liver of athymic mice was markedly lower when compared to human islets grafted to the kidney. Islets implanted into their physiological environment, the pancreas, were markedly better revascularized. Insulin content, glucose-stimulated insulin release, (pro)insulin biosynthesis and glucose oxidation rate were markedly decreased in transplanted islets retrieved from the liver, both when compared to endogenous and transplanted islets retrieved from the pancreas. Only minor changes in metabolic functions were observed in islets implanted into the pancreas when compared to endogenous islets. The present findings demonstrate that the microenvironment has a major impact on the engraftment of transplanted islets. Elucidating the beneficial factors that promote engraftment would improve the survival and long-term function of transplanted islets. Ultimately, islet transplantation may be provided to an increased number of patients with type 1 diabetes.

Type 1 diabetes (T1D) is a chronic autoimmune disease targeted against the pancreatic β-cells. Proinflammatory cytokines are considered to play a major role in the destruction of the insulin-producing β-cells. This thesis studied strategies to counteract proinflammatory cytokines in experimental T1D. Both animal models for T1D as well as β-cell preparations exposed in vitro to putative noxious conditions were examined. In the first study we observed that cytokine treatment of mouse pancreatic islets lacking inducible nitric oxide synthase (iNOS) induced a prolongation of the early stimulatory phase of glucose stimulated insulin secretion. Various experiments led to the conclusion that this prolonged stimulatory effect may involve the DAG/PLD/PKC pathway. Next, we transplanted mouse islets deficient in iNOS to spontaneously diabetic NOD mice. We observed a normalization of hyperglycemia but not a delayed allograft rejection compared to transplanted wild type islets. Thus, absence of iNOS in the graft was not sufficient to prolong allograft survival. In paper III we found that sustained glucose stimulation of rat pancreatic islets was coupled to a decreased conversion of proinsulin to insulin. Islet treatment with IL-1β was also coupled to a decreased proinsulin conversion. Islet proconvertase activity may be a target in islet damage. In paper IV prolactin (PRL) was administered to mice in the multiple low dose streptozotocin model and we observed that PRL enhanced a Th2 response. This may contribute to the protective action by PRL in this model of autoimmune T1D. Finally, by examining β-cells overexpressing Suppressor of cytokine signalling 3 (SOCS-3) it was found that this could inhibit IL-1β induced signalling through the NF-κB and MAPK pathways. SOCS-3 overexpression also inhibited apoptosis induced by cytokines in primary β-cells. Lastly, we demonstrated that SOCS-3 transgenic islets were protected in an allogeneic transplantation model.

Aim: To investigate the quality of life and the social life situation, with special focus on the consequenses of fear of hypoglycemia (FoH), in Islet transplanted patients. Method: 11 patients were included, four women and seven men, who have been Islet tranplanted at Uppsala University Hospital during the years 2001-2009. Two questionaires, Short Form 36 (SF-36) and the Swedish version Hypoglycemia Fear Survey (Swe-HFS) were used to investigate the quality of life, in relation to fear of hypoglycemia. Also, telephone interviews were conducted to investigate the patients social life situation in relation to FoH, after Islet transplantation and were analysed using content analysis method. Results: The mean value for quality of life was lower than that in the normal population. Three out of ten patients experienced FoH. Three predominant themes were revealed, one theme associated with pre- transplant, was “Struggle for control of Social Life Situation” and two themes associated with post-transplant, were “Regain power and controll of  Social Life Situation” and “At Peace with the balance between the Present and the Future”. Conclusion: The patients experienced improved control over social life situation and quality of life in relation to FoH may been improved following islet tranplantation. / Syfte: Att undersöka ö-cellstransplanterade patienters livskvalitet och sociala livssituation med speciellt fokus på oro/rädsla för hypoglykemi. Metod: I studien inkluderades 11 patienter, fyra kvinnor och sju män, vilka genomgått ö-cellstransplantation vid Akademiska Sjukhuset i Uppsala under perioden 2001-2009. Två frågeformulär, Short Form 36 (SF-36) och den svenska versionen av Hypoglycemia Fear Survey (Swe-HFS) användes för att undersöka patienternas livskvalitet relaterat till oro/rädsla för hypoglykemi. Telefonintervjuer genomfördes för att undersöka patienternas sociala livssituation efter genomgången ö-cellstransplantation relaterat till oro/rädsla för hypoglykemi och analyserats med innehållsanalys. Resultat: Medelvärdet för hälsorelaterad livskvalitet var lägre jämfört med normalbefolkningen och tre av tio deltagare upplevde oro/rädsla för hypoglykemi. Tre övergripande teman med koppling till social livssituation identifierades, ett tema före genomgången ö-cellstransplantation, var ”Kampen om kontroll över social livssituation”, och två teman efter genomförd transplantation, var ”Återtagande av makt och kontroll över social livssituation” samt ”Tillfreds med balans mellan nuet och framtiden”. Konklusion: Patienterna upplevde att kontrollen över den sociala livssituationen och livskvalitet i relation till oro/rädsla för hypoglykemi förbättrades efter genomgången ö-cellstransplantation.

Islet transplantation has emerged as a promising cell-based therapy for the treatment of diabetes, but its clinical efficacy remains limited by deleterious host responses that underlie islet destruction. In this dissertation, we describe the assembly of cell surface-supported thin films that confer molecular-level control over the composition and biophysicochemical properties of the islet surface with implications for improving islet engraftment. Specifically, the process of layer-by-layer (LbL) polymer self assembly was employed to generate nanothin films of diverse architecture with tunable properties directly on the extracellular surface of individual islets. Importantly, these studies are the first to report in vivo survival and function of nanoencapsulated cells, and have helped establish a conceptual framework for translating the diverse applications of LbL films to cellular interfaces. Additionally, through proper design of film constituents, coatings displaying ligands and bioorthogonally reactive handles may be generated, providing a modular strategy for incorporating exogenously derived regulators of host responses alongside native constituents of the islet surface. Towards this end, a strategy was developed to tether thrombomodulin to the islet surface in a site-specific manner, thereby facilitating local generation of the powerful anti-inflammatory agent, activated protein C. Collectively, this work offers novel biomolecular strategies for cell surface engineering with broad biomedical and biotechnological applications in cell-based therapeutics and beyond.

Le récepteur DcR3 (Decoy receptor 3) est un membre de la famille des récepteurs aux facteurs de nécrose tumorale (TNF). Il est fortement exprimé dans les tissus humains normaux ainsi que les tumeurs malignes. DcR3 est un récepteur pour trois ligands de la famille du TNF tels que FasL, LIGHT et TL1A. Étant une protéine soluble donc dépourvue de la portion transmembranaire et intracytoplasmique, le récepteur DcR3 est incapable d’effectuer une transduction de signal intracellulaire à la suite de son interaction avec ses ligands. De ce fait, DcR3 joue un rôle de compétiteur pour ces derniers, afin d’inhiber la signalisation via leurs récepteurs fonctionnels tels que Fas, HVEM/LTbetaR et DR3. Lors de nos précédentes études, nous avons pu démontrer, que DcR3 pouvaist moduler la fonction des cellules immunitaires, et aussi protéger la viabilité des îlots de Langerhans. À la suite de ces résultats, nous avons généré des souris DcR3 transgéniques (Tg) en utilisant le promoteur du gène β-actine humaine afin d’étudier plus amplement la fonction de ce récepteur. Les souris Tg DcR3 ont finalement développé le syndrome lupus-like (SLE) seulement après l’âge de 6 mois. Ces souris présentent une variété d'auto-anticorps comprenant des anticorps anti-noyaux et anti-ADN. Elles ont également manifesté des lésions rénales, cutanées, hépatiques et hématopoïétiques. Contrairement aux modèles de lupus murin lpr et gld, les souris DcR3 sont plus proche du SLE humain en terme de réponse immunitaire de type Th2 et de production d'anticorps d'anti-Sm. En péus, nous avons constaté que les cellules hématopoïétiques produisant DcR3 sont suffisantes pour causer ces pathologies. DcR3 peut agir en perturbant l’homéostasie des cellules T pour interférer avec la tolérance périphérique, et ainsi induire l'autoimmunité. Chez l'humain, nous avons détecté dans le sérum de patients SLE des niveaux élevés de la protéine DcR3. Chez certains patients, comme chez la souris, ces niveaux sont liés directement aux titres élevés d’IgE. Par conséquent, DcR3 peut représenter un facteur pathogénique important du SLE humain. L’étude des souris Tg DcR3, nous a permis aussi d’élucider le mécanisme de protection des îlots de Langerhans. Le blocage de la signalisation des ligands LIGHT et TL1A par DcR3 est impliqué dans une telle protection. D'ailleurs, nous avons identifié par ARN microarray quelques molécules en aval de cette interaction, qui peuvent jouer un rôle dans le mécanisme d’action. Nous avons par la suite confirmé que Adcyap1 et Bank1 joue un rôle critique dans la protection des îlots de Langerhans médiée par DcR3. Notre étude a ainsi élucidé le lien qui existe entre la signalisation apoptotique médiée par Fas/FasL et la pathogénèse du SLE humain. Donc, malgré l’absence de mutations génétiques sur Fas et FasL dans le cas de cette pathologie, DcR3 est capable de beoquer cette signalisation et provoquer le SLE chez l’humain. Ainsi, DcR3 peut simultanément interférer avec la signalisation des ligands LIGHT et TL1A et causer un phénotype plus complexe que les phénotypes résultant de la mutation de Fas ou de FasL chez certains patients. DcR3 peut également être utilisé comme paramètre diagnostique potentiel pour le SLE. Les découvertes du mécanisme de protection des îlots de Langerhans par DcR3 ouvrent la porte vers de nouveaux horizons afin d'explorer de nouvelles cibles thérapeutiques pour protéger la greffe d'îlots. / Decoy receptor 3 (DcR3) is a member of the tumor necrosis factor (TNF) receptor family, and is widely expressed in human normal tissues and malignant tumors. It is a decoy receptor of three TNF family members, i.e., FasL, LIGHT and TL1A. The interaction of DcR3 and its ligands will not transmit signal into cells via DcR3 because DcR3 is a soluble protein without a transmembrane and intracellular segment. Thereby, DcR3 competitively inhibits signaling through three functional receptors, i.e., Fas, HVEM/LTbetaR and DR3. In previous studies, we found that DcR3 could modulate immune cell function, and protect islet viability. Herein, we generated DcR3 transgenic (Tg) mice driven by the human β-actin promoter to further investigate the function of DcR3. Interestingly, the DcR3 Tg mice developed a lupus-like syndrome at 6 months of age. They presented a variety of autoantibodies including anti-nucleus and anti-dsDNA antibodies. They also manifested renal, dermal, hepatic and hematopoietic lesions. Compared to lpr and gld mouse lupus models, DcR3 Tg mice more closely resembled human SLE in terms of Th2-biased immune response and anti-Sm antibody production. Furthermore, we found that DcR3-producing hematopoietic cell were sufficient to cause these pathological changes. Mechanistically, DcR3 may break T-cell homeostasis to interfere with peripheral tolerance, and then induce autoimmunity. In humans, we detected high DcR3 levels in SLE patient sera. The high DcR3 levels were related to elevated IgE titer in some SLE patients, as was the case in the mouse model. Therefore, DcR3 may represent an important pathogenetic factor of human SLE. Utilizing the DcR3 Tg mouse, we further elucidated the mechanism by which DcR3 protected islets from primary nonfunction (PNF). Blocking of LIGHT and TL1A signaling by DcR3 are involved in such protection. Moreover, by mRNA microarray we identified possible downstream molecules, which may mediate such protection. We confirmed that Adcyap1 and Bank1 played critical roles in mediating DcR3’s effect in islet protection. Our studies resolved a puzzle about the relationship between the Fas/FasL apoptosis signaling pathway and the pathogenesis of human SLE. DcR3 can block Fas/FasL pathway even if there is no genetic mutation in Fas and FasL. DcR3 can simultaneously interfere with LIGHT and TL1A signaling to cause a more complex phenotype than the simple Fas or FasL mutation in patients. DcR3 can also be employed as a potential diagnostic parameter for SLE. The discovery of the mechanism of DcR3 in protecting islets allows us to explore novel therapeutic targets to protect islet graft.